CVE-2004-1824
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers...
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers to inject arbitrary web script or HTML via the what parameter to memberlist.php.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers to inject arbitrary web script or HTML via the what parameter to memberlist.php.
- Record
CVE-2004-1824- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers to inject arbitrary web script or HTML via the what parameter to memberlist.php.
- Record
CVE-2004-1824- Updated
- 2026-11-02
EUVDEUVD-2004-1817 No score
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers to inject arbitrary web script or HTML via the what parameter to memberlist.php.
- Record
EUVD-2004-1817- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-33v4-3wc6-5p2f No score
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers...
Cross-site scripting (XSS) vulnerability in Jelsoft vBulletin before 3.0 allows remote attackers to inject arbitrary web script or HTML via the what parameter to memberlist.php.
- Record
GHSA-33v4-3wc6-5p2f- Updated
- 2026-11-02
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | vBulletin 2.0/2.2.x - 'memberlist.php' Cross-Site Scripting | 2002-11-22 |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, Exploit-DB, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2004-1824 is a medium vulnerability (CVSS 4.3), published December 31, 2004. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 2.57%, the 85th percentile. No source names a fixed version.